Literature DB >> 31109702

Feasibility of multiparametric imaging with PET/MR in nasopharyngeal carcinoma: A pilot study.

Caineng Cao1, Pengfei Yang2, Yuanfan Xu3, Tianye Niu2, Qiaoying Hu1, Xiaozhong Chen4.   

Abstract

OBJECTIVE: The aim of this pilot study was to explore the integrated positron emission tomography and magnetic resonance imaging scanner (PET/MR) for biological characterization of nasopharyngeal carcinoma (NPC) and potential therapeutic applications of dose painting (DP). PATIENTS AND METHODS: Twenty-one NPC patients with PET/MR were included in this study. Overlap of tumor volumes was analyzed on T2-weighted images (volume of interest, VOIT2), diffusion-weighted magnetic resonance imaging (VOIDWI) and 18F-fluorodeoxyglucose positron emission tomography (VOIPET). The overlap percentages of low-metabolic sub-region (cluster 1) and high-metabolic sub-region (cluster 2) in VOIPET and VOIDWI were analyzed by cluster analysis.
RESULTS: Both the VOIDWI and VOIPET were encompassed in the VOIT2, respectively 99.6% and 97.5%. The median tumor overlap was 94.4% (VOIDWI within VOIPET). The median overlap of cluster 2 in VOIPET and VOIDWI was 43.61% (27.67-52.66%) and 21.86%(10.47-40.89%), respectively. The median overlap of cluster 1 in VOIPET and VOIDWI was 48.03% (23.91-63.15%) and 24.40% (7.44-51.44%), respectively. Separation between clusters appeared to be defined by a SUV value.
CONCLUSION: For NPC, the VOIs of DWI and FDG PET were not overlapped completely and the volume defined by cluster-analysis might be meaningful for DP.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Diffusion-weighted imaging; FDG-PET; Nasopharyngeal carcinoma; PET/MR

Mesh:

Substances:

Year:  2019        PMID: 31109702     DOI: 10.1016/j.oraloncology.2019.04.021

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  4 in total

1.  A head-to-head comparison of 68Ga-DOTA-FAPI-04 and 18F-FDG PET/MR in patients with nasopharyngeal carcinoma: a prospective study.

Authors:  Chunxia Qin; Fang Liu; Jing Huang; Weiwei Ruan; Qingyao Liu; Yongkang Gai; Fan Hu; Dawei Jiang; Yu Hu; Kunyu Yang; Xiaoli Lan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-02-20       Impact factor: 9.236

2.  Multiparametric positron emission tomography/magnetic resonance imaging in nasopharyngeal carcinoma: Correlations between magnetic resonance imaging functional parameters and 18F-fluorodeoxyglucose positron emission tomography imaging biomarkers and their predictive value for treatment failure.

Authors:  Sheng-Chieh Chan; Shu-Hang Ng; Chih-Hua Yeh; Kai-Ping Chang
Journal:  Tzu Chi Med J       Date:  2020-04-10

3.  Locoregional Extension Patterns of Nasopharyngeal Carcinoma Detected by FDG PET/MR.

Authors:  Caineng Cao; Yuanfan Xu; Shuang Huang; Feng Jiang; Ting Jin; Qifeng Jin; Yonghong Hua; Qiaoying Hu; Xiaozhong Chen
Journal:  Front Oncol       Date:  2021-12-13       Impact factor: 6.244

4.  Preliminary clinical results for PET/MR compared with PET/CT in patients with nasopharyngeal carcinoma.

Authors:  Yong Cheng; Le Bai; Jingjie Shang; Yongjin Tang; Xueying Ling; Bin Guo; Jian Gong; Lu Wang; Hao Xu
Journal:  Oncol Rep       Date:  2019-10-30       Impact factor: 3.906

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.